Skip to main content

IHE · iShares U.S. Pharmaceuticals ETF

iShares Trust

SEC fund profile
$108.41 -1.12% At close · Nov 17
Net assets $1,138,327,188
Holdings59
1 month
+4.77%
Year to date
+28.95%
52-week range
$80.82–$112.29
30-session avg volume
278,948

Market performance

Adjusted close · up to five years

Since Nov 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000009417
Report date
Jun 30, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings76.11%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Securities-lending collateral (1 row, $71,059,530, 6.24% of net assets) is cash received from borrowers of the fund's securities, so it is left out of this figure and of the allocations. The holdings table lists it, labelled.

Asset allocation

EC99.92%
STIV0.07%
DE0.00%

Country allocation

US90.15%
GB4.33%
IE3.78%
CA1.39%
SG0.20%
KY0.15%

Portfolio holdings

Latest linked SEC Form NPORT-P report. Pull holdings through the ETF holdings API or MCP →

Export CSV
HoldingValueWeight
JOHNSON & JOHNSON $255,484,67722.44%
ELI LILLY AND COMPANY $253,226,06022.25%
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares Lending collateral $71,059,5306.24%
MERCK & CO., INC. $51,774,0644.55%
BRISTOL-MYERS SQUIBB COMPANY $49,725,6574.37%
ROYALTY PHARMA PLC $49,346,4784.33%
VIATRIS INC. $48,049,6094.22%
PFIZER INC. $45,133,4573.96%
ZOETIS INC. $42,416,1553.73%
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY $39,283,6523.45%
ELANCO ANIMAL HEALTH INCORPORATED $31,936,2002.81%
AXSOME THERAPEUTICS, INC. $27,490,3632.41%
CORCEPT THERAPEUTICS INCORPORATED $21,584,7291.90%
LIGAND PHARMACEUTICALS INCORPORATED $16,458,8061.45%
Definium Therapeutics Inc $15,807,0861.39%
Liquidia Corp $14,553,5951.28%
INDIVIOR PHARMACEUTICALS, INC. $12,997,5651.14%
Crinetics Pharmaceuticals Inc $10,250,6850.90%
ORGANON & CO. $9,248,1990.81%
Edgewise Therapeutics Inc $7,959,1730.70%
AMNEAL PHARMACEUTICALS, INC. $7,756,2470.68%
Enliven Therapeutics Inc $7,177,8260.63%
SUPERNUS PHARMACEUTICALS, INC. $7,021,1960.62%
Tarsus Pharmaceuticals Inc $6,469,3510.57%
Veradermics Inc $6,400,8710.56%
Alumis Inc $6,233,6010.55%
NEKTAR THERAPEUTICS $6,134,7630.54%
PRESTIGE CONSUMER HEALTHCARE INC. $5,813,4540.51%
Trevi Therapeutics Inc $5,716,4300.50%
OCULAR THERAPEUTIX, INC. $4,472,4990.39%
INNOVIVA, INC. $4,140,1470.36%
Amylyx Pharmaceuticals Inc $3,944,2320.35%
ANI PHARMACEUTICALS, INC. $3,924,1030.34%
MBX Biosciences Inc $3,822,4340.34%
HARMONY BIOSCIENCES HOLDINGS, INC. $3,779,5040.33%
PERRIGO COMPANY PUBLIC LIMITED COMPANY $3,735,4960.33%
HARROW, INC. $3,661,5090.32%
NUVATION BIO INC. $3,598,8540.32%
XERIS BIOPHARMA HOLDINGS, INC. $3,552,1280.31%
Rapport Therapeutics Inc $3,105,2480.27%
Collegium Pharmaceutical, Inc. $3,049,3790.27%
EYEPOINT, INC. $2,926,6240.26%
AtaiBeckley Inc $2,667,4630.23%
PACIRA BIOSCIENCES, INC. $2,590,4800.23%
WAVE Life Sciences Ltd $2,290,4820.20%
Maze Therapeutics Inc $2,183,0940.19%
LB Pharmaceuticals Inc $2,050,2800.18%
BIOAGE Labs Inc $2,032,8100.18%
Septerna Inc $1,996,1710.18%
AMPHASTAR PHARMACEUTICALS, INC. $1,785,7890.16%

Showing the top 50 of 59 holdings. Create a free account to see every holding and download the CSV.